SEK 42.3
(0.83%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.76 Billion SEK | 9.18% |
2022 | 3.51 Billion SEK | 16.99% |
2021 | 3 Billion SEK | 20.04% |
2020 | 2.5 Billion SEK | 1.8% |
2019 | 2.46 Billion SEK | 5.85% |
2018 | 2.32 Billion SEK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 981 Million SEK | -6.66% |
2024 Q2 | 1 Billion SEK | -15.29% |
2023 Q2 | 940 Million SEK | -0.74% |
2023 FY | 3.84 Billion SEK | 9.18% |
2023 Q4 | 1.05 Billion SEK | 16.52% |
2023 Q3 | 902 Million SEK | -4.04% |
2023 Q1 | 947 Million SEK | -8.68% |
2022 Q1 | 799 Million SEK | -10.73% |
2022 Q4 | 1.03 Billion SEK | 23.16% |
2022 Q3 | 842 Million SEK | 0.0% |
2022 Q2 | 842 Million SEK | 5.38% |
2022 FY | 3.51 Billion SEK | 16.99% |
2021 Q1 | 681 Million SEK | -16.85% |
2021 FY | 3 Billion SEK | 20.04% |
2021 Q2 | 712 Million SEK | 4.55% |
2021 Q4 | 895 Million SEK | 24.31% |
2021 Q3 | 720 Million SEK | 1.12% |
2020 FY | 2.5 Billion SEK | 1.8% |
2020 Q3 | 600 Million SEK | 8.11% |
2020 Q1 | 588.5 Million SEK | 0.0% |
2020 Q4 | 819 Million SEK | 36.5% |
2020 Q2 | 555 Million SEK | -5.69% |
2019 FY | 2.46 Billion SEK | 5.85% |
2018 FY | 2.32 Billion SEK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AddLife AB (publ) | 3.01 Billion SEK | -24.818% |
Biotage AB (publ) | 637 Million SEK | -490.581% |
Bonesupport Holding AB (publ) | 510.93 Million SEK | -636.304% |
Doxa AB (publ) | -259.5 Million SEK | 1549.711% |
Elekta AB (publ) | 3.39 Billion SEK | -10.973% |
iZafe Group AB (publ) | 35.92 Million SEK | -10370.942% |
Ortivus AB (publ) | 48.45 Million SEK | -7664.225% |
Ortivus AB (publ) | 48.45 Million SEK | -7664.225% |
Q-linea AB (publ) | -43 Thousand SEK | 8748937.209% |
S2Medical AB (publ) | 20.3 Million SEK | -18431.228% |